Abstract | BACKGROUND AND AIMS: Previous studies investigating the correlation between plasma sialic acid and the severity of atherosclerosis present conflicting results. In atherosclerosis patients, plasma levels of N-acetylneuraminic acid (NANA) are increased; however, the underlying mechanisms have not yet been clarified. We assume the increased NANA level may be a compensatory mechanism due to oxidative stress and/or inflammation. The aim of this study is to investigate whether supplementation of NANA could attenuate the progression of atherosclerosis. METHODS: RESULTS: CONCLUSIONS: NANA exhibited triglyceride lowering, anti-oxidation, and RCT promoting activities, and therefore NANA supplementation may be a new strategy for prevention and treatment of atherosclerosis.
|
Authors | Shoudong Guo, Hua Tian, Rongrong Dong, Nana Yang, Ying Zhang, Shutong Yao, Yongjun Li, Yawei Zhou, Yanhong Si, Shucun Qin |
Journal | Atherosclerosis
(Atherosclerosis)
Vol. 251
Pg. 183-191
(08 2016)
ISSN: 1879-1484 [Electronic] Ireland |
PMID | 27344369
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Antioxidants
- Lipids
- Triglycerides
- Tumor Necrosis Factor-alpha
- Intercellular Adhesion Molecule-1
- Cholesterol
- Quercetin
- N-Acetylneuraminic Acid
- Oxygen
|
Topics |
- Animals
- Antioxidants
(chemistry)
- Aorta
(metabolism)
- Atherosclerosis
(drug therapy)
- Biological Assay
- Cholesterol
(blood)
- Inflammation
- Intercellular Adhesion Molecule-1
(blood)
- Lipids
(blood)
- Liver
(metabolism)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Knockout, ApoE
- N-Acetylneuraminic Acid
(therapeutic use)
- Oxidative Stress
- Oxygen
(chemistry)
- Quercetin
(pharmacology)
- Triglycerides
(genetics)
- Tumor Necrosis Factor-alpha
(blood)
|